ABSTRACT Rat liver 6-phosphofructokinase (ATP-D-fructose-6-phosphate 1-phosphotransferase, EC 2.7.1.11) was partially purified free of interfering enzymes by a rapid procedure. Fructose 2,6-bisphosphate, at micromolar concentrations, greatly stimulated the enzyme by increasing its affinity for fructose 6-phosphate and relieving the inhibition by ATP. Its action was synergistic with that of AMP. As a stimulator of liver phosphofructokinase, fructose 2,6-bisphosphate was approximately 1000-and 2500-fold more efficient than fructose 1,6-bisphosphate and glucose 1,6-bisphosphate, respectively. The concentration at which a half-maximal effect was obtained with the hexose bisphosphates was dependent upon the experimental conditions. It was relatively high at physiological concentrations of substrates, AMP, and Pi, and under these conditions the positive effect of fructose 1,6-bisphosphate was no longer detectable. This was probably due to the negative effect of fructose 1,6-bisphosphate as a reaction product inhibitor. It is concluded that fructose 2,6-bisphosphate rather than fructose 1,6-bisphosphate controls, in association with other effectors, the activity of phosphofructoldnase in the liver.
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There is a general agreement in the literature that 6-phosphofructokinase (ATP:D-fructose-6-phosphate l-phosphotransferase, EC 2.7.1.11) plays a major role in the control ofglycolysis in nearly all types of cells (1) (2) (3) (4) (5) (6) . The activity of this enzyme is controlled by several metabolites, most notably its two substrates, fructose 6-phosphate and ATP. The rate of the reaction is a sigmoidal function of fructose 6-phosphate concentration, and the saturation curve is shifted to the left in the presence of positive effectors, among which fructose 1,6-bisphosphate (7, 8) , the product of the reaction, and AMP are currently believed to play a major role. Negative effectors such as ATP and citrate have the opposite effect. The rate ofthe reaction plotted as a function of ATP concentration exhibits a typical inhibition by excess substrate. This inhibition is relieved by the positive effectors and by large concentrations of fructose 6-phosphate, whereas it is intensified by the negative effectors.
Fructose 2,6-bisphosphate is a newly recognized, extremely effective, positive effector of liver and muscle phosphofructokinase (9) . Its concentration in the liver is greatly increased under conditions in which glycolysis is active and is decreased by glucagon (10) . It has also been found to inhibit, at micromolar concentrations, liver and muscle fructose-1,6-bisphosphatase (11) . It therefore appears to be a major regulator of both glycolysis and gluconeogenesis in the liver. The purpose of the present work was to investigate the action of fructose 2,6-bisphosphate on the kinetics of liver phosphofructokinase and to compare it to that of its isomers fructose 1,6-bisphosphate and glucose 1,6- pyruvate kinase (20 ,g/ml) and lactate dehydrogenase (25 Mg/ ml) were used as coupling enzymes in the presence of 1 mM phosphoenolpyruvate (ADP-coupled assay). The concentration of other reagents was the same in both assay systems and the reaction was always initiated by the addition of ATP. In both methods, the reaction rate decreased during the first 5 min and then remained almost constant for another 5 min; this latter rate was taken for the measurement of activity. Lactate dehydrogenase was assayed according to Bergmeyer and Bernt (14) . One unit of phosphofructokinase or lactate dehydrogenase is the amount of enzyme that converts 1 Pmol of substrate per min under the conditions of the assay. Protein concentrations were determined by the method of Lowry et al. (15) after precipitation in 10% trichloroacetic acid. Purification of Liver Phosphofructokinase. The object ofthe purification was to render phosphofructokinase essentially free of enzymes that might interfere with kinetic studies. The procedure developed is simple and can be carried out in a single day. It takes advantage ofthe relatively uncommon propensities ofliver phosphofructokinase to precipitate at low concentrations of ammonium sulfate and to form aggregates that can be separated from most interfering enzymes by gel filtration. The initial steps (homogenization, fractionation by high-speed centrifugation, and ammonium sulfate precipitation) are the same as described by Reinhart and Lardy (12) , with the main exception that the heat-treatment step was omitted. After the ammonium sulfate precipitation, the clarified solution (4 ml, corresponding to 8 g ofliver) was layered onto a column (2.6 X 40 cm) of Sepharose CL-6B (molecular weight fractionation range, 10,000-4,000,000) equilibrated with a buffer containing 20 mM KPi, 50 mM NaF, 1 mM fructose 6-phosphate, 20 ,uM EDTA, and 5 mM dithiothreitol (pH 7.6). The elution was performed with the same buffer at a rate of 0.6 ml/min, and 3-ml fractions were collected. Phosphofructokinase was eluted soon after the first peak ofproteins corresponding to the void volume, and well before lactate dehydrogenase (Mr 140,000) (Fig. 1) . The peak fractions were pooled and dialyzed overnight against 200 vol of a buffer containing 20 mM KPj, 2 mM MgSO4, 1 mM fructose 6-phosphate, 100 AM EDTA, 2 mM dithiothreitol, and 25% (wt/vol) glycerol. The purified enzyme (0.8 unit/mg) contained only trace amounts of NADH oxidoreductase, lactate dehydrogenase, fructose-1,6-bisphosphatase, aldolase, and myokinase. Fig. 2A) and decreased the inhibitory action ofATP (Fig.  2B ). These effects were obtained at concentrations of the effector below 1 ILM.
In order to study the concentration dependence of the stimulatory effect, the enzyme was assayed under conditions in which no activity could be detected in the absence of fructose 2,6-bisphosphate. It is apparent from Fig. 3 that the response was greatly dependent on the concentration of AMP (Fig. 3A) and the two substrates, fructose 6-phosphate and ATP (Fig. 3B) . A greater sensitivity was observed in the presence ofincreasing concentrations of fructose 6-phosphate or AMP and decreasing concentrations of ATP. Under all conditions a clear cooperativity for fructose 2,6-bisphosphate was observed.
The synergism with AMP is further illustrated by the data shown in Fig. 4 . In this experiment concentrations of ATP (2.5 mM) and fructose 6-phosphate (50 ,uM) were close to physiological and almost no activity was observed in the absence ofthe positive effectors, AMP and fructose 2,6-bisphosphate. Neither AMP (2.5 mM) nor fructose 2,6-bisphosphate (2.5 ,uM) alone was able to stimulate phosphofructokinase activity. When the two effectors were combined, however, the enzyme was stimulated to various degrees. The plateau reached in the presence of 2.5 ,uM fructose 2,6-bisphosphate and 0.25 mM AMP cor- Fig. 5 shows that in the presence of 2 mM fructose 6-phosphate and 1 mM AMP, a half-maximal effect was obtained at approximately 0.04 p.M fructose 2,6-bisphosphate, 40 p.M fructose 1,6-bisphosphate, and 100 ,uM glucose 1,6-bisphosphate. An inhibition by millimolar concentrations of fructose 1,6-bisphosphate was also apparent. At more physiological concentrations of substrate and effectors, all curves were shifted to the right and the stimulatory effect of fructose 1,6-bisphosphate was barely apparent (not shown). No effect was discernible at 50 ,uM fructose 6-phosphate, 0.1 mM AMP, 2.5 mM ATP, and 5 mM Pi (physiological concentrations).
DISCUSSION
In a recent investigation of the kinetics of rat liver phosphofructokinase, Reinhart and Lardy (12) reached the conclusion that, in the presence of 3 mM ATP, physiological concentrations of positive effectors (fructose 1,6-bisphosphate, AMP, and Pi) failed to activate phosphofructokinase sufficiently to account for its function at fructose 6-phosphate levels found in the cell. Our data (Fig. 4) confirm this observation and indicate that fructose 2,6-bisphosphate is most likely the missing stimulator, which was unknown by Reinhart and Lardy (12) and which allows glycolysis to operate in the liver.
Among the various effectors that could regulate phosphofructokinase in vivo, fructose 1,6-bisphosphate and AMP are usually considered to be the most important (1) (2) (3) (4) (5) (6) (7) (8) . The role of fructose 1,6-bisphosphate, which has been greatly emphasized (7, 8) , deserves special comment. From the work of Mansour and coworkers (16, 17) (17) . It therefore appears likely that the high-affinity site is always saturated under physiological conditions and that the low-affinity site is the only one that is important for the control of the enzymatic activity.
In agreement with this interpretation, a stimulation ofphosphofructokinase was perceptible only at concentrations of fructose 1,6-bisphosphate greater than 1 ILM (Fig. 5) Fructose 2,6-bisphosphate and AMP appear, therefore, to be the two main positive effectors that, together with the substrate fructose 6-phosphate, control the activity ofphosphofructokinase. Cooperativity was observed for fructose 6-phosphate ( Fig. 2A) , fructose 2,6-bisphosphate (Fig. 3) , and AMP (Fig. 4) . Their effects were also synergistic, indicating that the substrate and the positive effectors cooperate to maintain the enzyme in the same active conformation. It should be noted that fructose 2,6-bisphosphate and AMP act synergistically to inhibit liver and muscle fructose-1,6-bisphosphatase (11) . In doing so, they reinforce their stimulatory effect on glycolysis. It may be speculated that an increased concentration of AMP would occur under anaerobic conditions and would be responsible for the Pasteur effect. Fructose 2,6-bisphosphate, on the other hand, would regulate glycolysis and gluconeogenesis under aerobic conditions (10) .
The conclusions that we have reached for liver phosphofructokinase apply, at least in part, to the enzyme present in other types of cells. Phosphofructokinases from muscle (9) and from pancreatic islets (20) are also highly sensitive to the action of fructose 2,6-bisphosphate, which increases their affinity for fructose 6-phosphate. Preliminary experiments performed with purified yeast phosphofructokinase (kindly provided by E. Hofmann, Leipzig) have also revealed a large stimulatory effect of fructose 2,6-bisphosphate, but ofa more complex type in which there were changes of both Km and Vma.
